450 related articles for article (PubMed ID: 26030409)
1. Cardiac metabolic pathways affected in the mouse model of barth syndrome.
Huang Y; Powers C; Madala SK; Greis KD; Haffey WD; Towbin JA; Purevjav E; Javadov S; Strauss AW; Khuchua Z
PLoS One; 2015; 10(6):e0128561. PubMed ID: 26030409
[TBL] [Abstract][Full Text] [Related]
2. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
[TBL] [Abstract][Full Text] [Related]
3. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
[TBL] [Abstract][Full Text] [Related]
4. Long-chain fatty acid oxidation and respiratory complex I deficiencies distinguish Barth Syndrome from idiopathic pediatric cardiomyopathy.
Chatfield KC; Sparagna GC; Specht KS; Whitcomb LA; Omar AK; Miyamoto SD; Wolfe LM; Chicco AJ
J Inherit Metab Dis; 2022 Jan; 45(1):111-124. PubMed ID: 34821394
[TBL] [Abstract][Full Text] [Related]
5. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
[TBL] [Abstract][Full Text] [Related]
6. Cardiac mitochondrial structure and function in tafazzin-knockdown mice.
Kim J; Lee K; Fujioka H; Tandler B; Hoppel CL
Mitochondrion; 2018 Nov; 43():53-62. PubMed ID: 30389594
[TBL] [Abstract][Full Text] [Related]
7. Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
Ikon N; Ryan RO
Lipids; 2017 Feb; 52(2):99-108. PubMed ID: 28070695
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients.
McKenzie M; Lazarou M; Thorburn DR; Ryan MT
J Mol Biol; 2006 Aug; 361(3):462-9. PubMed ID: 16857210
[TBL] [Abstract][Full Text] [Related]
9. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
[TBL] [Abstract][Full Text] [Related]
10. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
[TBL] [Abstract][Full Text] [Related]
11. Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome.
Gaspard GJ; McMaster CR
Chem Phys Lipids; 2015 Dec; 193():1-10. PubMed ID: 26415690
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.
Soustek MS; Falk DJ; Mah CS; Toth MJ; Schlame M; Lewin AS; Byrne BJ
Hum Gene Ther; 2011 Jul; 22(7):865-71. PubMed ID: 21091282
[TBL] [Abstract][Full Text] [Related]
13. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
Zhu S; Chen Z; Zhu M; Shen Y; Leon LJ; Chi L; Spinozzi S; Tan C; Gu Y; Nguyen A; Zhou Y; Feng W; Vaz FM; Wang X; Gustafsson AB; Evans SM; Kunfu O; Fang X
Circ Heart Fail; 2021 Jun; 14(6):e008289. PubMed ID: 34129362
[TBL] [Abstract][Full Text] [Related]
14. Cardiolipin metabolism and the role it plays in heart failure and mitochondrial supercomplex formation.
Mejia EM; Cole LK; Hatch GM
Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):98-106. PubMed ID: 24801725
[TBL] [Abstract][Full Text] [Related]
15. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.
Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S
Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974
[TBL] [Abstract][Full Text] [Related]
16. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
[TBL] [Abstract][Full Text] [Related]
17. Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy.
Cole LK; Mejia EM; Sparagna GC; Vandel M; Xiang B; Han X; Dedousis N; Kaufman BA; Dolinsky VW; Hatch GM
J Mol Cell Cardiol; 2020 Jul; 144():24-34. PubMed ID: 32418915
[TBL] [Abstract][Full Text] [Related]
18. Cardiolipin-deficient cells have decreased levels of the iron-sulfur biogenesis protein frataxin.
Li Y; Lou W; Grevel A; Böttinger L; Liang Z; Ji J; Patil VA; Liu J; Ye C; Hüttemann M; Becker T; Greenberg ML
J Biol Chem; 2020 Aug; 295(33):11928-11937. PubMed ID: 32636300
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.
Russo S; De Rasmo D; Signorile A; Corcelli A; Lobasso S
Sci Rep; 2022 Nov; 12(1):19847. PubMed ID: 36400945
[TBL] [Abstract][Full Text] [Related]
20. Metabolic switch from fatty acid oxidation to glycolysis in knock-in mouse model of Barth syndrome.
Chowdhury A; Boshnakovska A; Aich A; Methi A; Vergel Leon AM; Silbern I; Lüchtenborg C; Cyganek L; Prochazka J; Sedlacek R; Lindovsky J; Wachs D; Nichtova Z; Zudova D; Koubkova G; Fischer A; Urlaub H; Brügger B; Katschinski DM; Dudek J; Rehling P
EMBO Mol Med; 2023 Sep; 15(9):e17399. PubMed ID: 37533404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
